<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03573089</url>
  </required_header>
  <id_info>
    <org_study_id>17.02</org_study_id>
    <nct_id>NCT03573089</nct_id>
  </id_info>
  <brief_title>Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)</brief_title>
  <acronym>PHOSPHATE</acronym>
  <official_title>An Investigator-initiated, International, Multi-centre, Prospective, Randomized, Open-label, Parallel-group, Superiority, and Pragmatic Large Simple Trial (LST) to Determine Whether the Currently Recommended Strategy of Intensive Reduction of Serum Phosphate Concentration Towards the Normal Level Results in Significant Patient-centred Benefits in End-stage Kidney Disease (ESKD) Patients Receiving Dialysis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Queensland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Health and Medical Research Council, Australia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Applied Health Research Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cambridge University Hospitals NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Otago</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Queensland</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      During end-stage kidney disease, clinical guidelines suggest reducing elevated phosphate&#xD;
      levels in the blood. However, the effect of lowering blood phosphate levels on important&#xD;
      patient-centred outcomes has never been tested. This trial will evaluate whether compared to&#xD;
      high levels, lowering blood phosphate levels would reduce death or major events due to heart&#xD;
      disease, improve physical health, and be cost-effective.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hyperphosphataemia is highly prevalent in patients with end-stage kidney disease (ESKD) and&#xD;
      associated with increased mortality risk. The Clinical Practice Guidelines suggest lowering&#xD;
      elevated phosphate levels towards the normal range (level 2C suggestion). However, trial data&#xD;
      demonstrating that treatments that lower serum phosphate will improve patient-centred&#xD;
      outcomes are lacking.&#xD;
&#xD;
      The primary objective is to test the hypothesis that compared to a liberal serum phosphate&#xD;
      concentration target of 2.0 to 2.5 mmol/L, intensive lowering of serum phosphate towards the&#xD;
      normal level (≤1.50 mmol/L) with phosphate binders reduces the risk of fatal or non-fatal&#xD;
      major cardiovascular events in ESKD patients receiving dialysis. The secondary objectives are&#xD;
      to test the hypothesis that intensive lowering of serum phosphate towards the normal level&#xD;
      with phosphate binders would improve physical health, fatigue, health-related quality of&#xD;
      life, patient satisfaction, and pruritus; and be cost-effective.&#xD;
&#xD;
      In this pragmatic, multinational, randomised controlled large simple trial, a total of 3600&#xD;
      adult ESKD patients receiving dialysis will be randomised either to intensive (≤1.50 mmol/L)&#xD;
      or liberalized (2.0-2.5 mmol/L) serum phosphate target. The choice and dose of phosphate&#xD;
      binders will be at the treating physician's discretion and local practice to achieve and&#xD;
      maintain serum phosphate concentration within the required target range according to&#xD;
      randomisation. The primary endpoint is the composite endpoint of cardiovascular death,&#xD;
      non-fatal major cardiovascular or peripheral arterial events. The secondary outcome measures&#xD;
      will be individual components of the primary composite endpoint, all-cause death, and&#xD;
      utility-based quality of life EQ5D-5L.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 10, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to a composite endpoint of cardiovascular death or non-fatal major cardiovascular event</measure>
    <time_frame>5 years</time_frame>
    <description>Time to a composite endpoint of cardiovascular death, non-fatal myocardial infarction or coronary revascularization, stroke, or peripheral arterial event.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to individual components of the primary composite endpoint,</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to all-cause death</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Utility-based quality of life EQ5D-5L</measure>
    <time_frame>5 years</time_frame>
    <description>EQ5D-5L will be used to assess patient self-reported quality of life measures.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Differences in the serum concentrations of phosphate, PTH, calcium, alkaline phosphatase and albumin</measure>
    <time_frame>Time Frame: 5 years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Phosphate-lowering medication usage</measure>
    <time_frame>5 years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Phosphate-lowering medication self-reported adherence</measure>
    <time_frame>5 years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Proportion of patients requiring parathyroidectomy</measure>
    <time_frame>5 years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Proportion of patients developing calciphylaxis</measure>
    <time_frame>5 years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Gastrointestinal Symptom Rating Scale</measure>
    <time_frame>5 years</time_frame>
    <description>The Gastrointestinal Symptom Rating Scale (GSRS) is a 15-item instrument designed to assess the symptoms associated with common GI disorders. It has five subscales (reflux, diarrhea, constipation, abdominal pain and indigestion). Subscale scores range from 1-7 and higher scores represent higher symptom burden i.e. more discomfort.</description>
  </other_outcome>
  <other_outcome>
    <measure>Itch/pruritus visual analog scale</measure>
    <time_frame>5 years</time_frame>
    <description>The Pruritis 5-D scale contains five domains: duration, degree, direction, disability and distribution. The scores of each of the five domains are achieved separately and then summed together to obtain a total 5-D score. 5-D scores can potentially range between 5 (no pruritus) and 25 (most severe pruritus).</description>
  </other_outcome>
  <other_outcome>
    <measure>Cost-effectiveness analysis:</measure>
    <time_frame>5 years</time_frame>
    <description>Difference in the incremental cost per Quality Adjusted Life Years gained</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">3600</enrollment>
  <condition>Kidney Failure, Chronic</condition>
  <condition>Hyperphosphatemia</condition>
  <arm_group>
    <arm_group_label>Liberal phosphate target</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Liberal serum phosphate target of 2.0 to 2.5 mmol/L.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intensive phosphate target</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intensive serum phosphate target of ≤1.50 mmol/L.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Liberal phosphate target</intervention_name>
    <description>All phosphate-lowering medications in use at baseline will be discontinued. Phosphate-lowering medications will be prescribed only if serum phosphate concentration exceeds 2.50 mmol/L. The choice and dosages of phosphate-lowering medications will be at the discretion of treating physicians and/or participants.</description>
    <arm_group_label>Liberal phosphate target</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intensive phosphate target</intervention_name>
    <description>This will be achieved by prescribing phosphate-lowering medications aimed to intensively lower serum phosphate concentration towards normal level (≤1.50 mmol/L). The choice and dosages of phosphate-lowering medications will be at the discretion of treating physicians and/or participants.</description>
    <arm_group_label>Intensive phosphate target</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age ≥45 years, or Age ≥18 years with diabetes,&#xD;
&#xD;
          2. ESKD on haemodialysis or peritoneal dialysis, for at least 3 months,&#xD;
&#xD;
          3. Currently prescribed at least one phosphate-lowering medication at any dose&#xD;
&#xD;
          4. Able to provide informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Elective kidney transplantation scheduled,&#xD;
&#xD;
          2. Concomitant major illness / comorbidity that may result in death in the next 6 months&#xD;
             in the view of the treating physician,&#xD;
&#xD;
          3. Participation in an interventional study that is likely to affect serum phosphate&#xD;
             concentration.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sunil Badve</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Queensland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ron Wald</last_name>
    <role>Principal Investigator</role>
    <affiliation>Unity Health Toronto</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rona Smith</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cambridge</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Suetonia Palmer</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Otago</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patrick Mark</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Glasgow</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rathika Krishnasamy</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Queensland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Walsh</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hamilton Centre for Kidney Research</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ron Wald</last_name>
    <phone>+1 416-867-3703</phone>
    <email>WaldR@smh.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rona Smith</last_name>
    <phone>+44 07929642380</phone>
    <email>rms50@cam.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Royal Prince Alfred Hosptial</name>
      <address>
        <city>Camperdown</city>
        <state>New South Wales</state>
        <zip>2050</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Snelling, Dr</last_name>
      <email>Paul.Snelling@health.nsw.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nepean Hospital</name>
      <address>
        <city>Kingswood</city>
        <state>New South Wales</state>
        <zip>2750</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Muralikrishna Komala, Dr</last_name>
      <email>Muralikrishna.GangadharanKomala@health.nsw.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St George Hospital</name>
      <address>
        <city>Kogarah</city>
        <state>New South Wales</state>
        <zip>2217</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sunil Badve, A/Prof</last_name>
      <email>s.badve@unsw.edu.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal North Shore Hospital</name>
      <address>
        <city>Saint Leonards</city>
        <state>New South Wales</state>
        <zip>2065</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emma O'Lone, Dr</last_name>
      <email>emma.olone@health.nsw.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Western Sydney Renal Service</name>
      <address>
        <city>Westmead</city>
        <state>New South Wales</state>
        <zip>2145</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Grahame Elder, A/Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wollongong Hospital</name>
      <address>
        <city>Wollongong</city>
        <state>New South Wales</state>
        <zip>2500</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hichaim Cheikh Hasan, Dr</last_name>
      <email>HichamIbrahim.CheikhHassan@health.nsw.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sunshine Coast University Hospital</name>
      <address>
        <city>Birtinya</city>
        <state>Queensland</state>
        <zip>4575</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rathika Krishnasamy, A/Prof</last_name>
      <email>Rathika.Krishnasamy@health.qld.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Brisbane and Women's Hospital</name>
      <address>
        <city>Brisbane</city>
        <state>Queensland</state>
        <zip>4006</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sharad Ratanjee, Dr</last_name>
      <email>sharad.ratanjee@health.qld.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Princess Alexandra Hospital</name>
      <address>
        <city>Brisbane</city>
        <state>Queensland</state>
        <zip>4110</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carmel Hawley, Prof</last_name>
      <email>David.Johnson2@health.qld.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bundaberg Hospital</name>
      <address>
        <city>Bundaberg</city>
        <state>Queensland</state>
        <zip>4670</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clyson Mutatiri, Dr</last_name>
      <email>Clyson.Mutatiri@health.qld.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cairns Hospital</name>
      <address>
        <city>Cairns</city>
        <state>Queensland</state>
        <zip>4870</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shyam Dheda, Dr</last_name>
      <email>Shyam.Dheda@health.qld.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fraser Coast Renal Service</name>
      <address>
        <city>Hervey Bay</city>
        <state>Queensland</state>
        <zip>4655</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krishan Madhan, Dr</last_name>
      <email>Krishan.Madhan@health.qld.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mackay Hospital</name>
      <address>
        <city>Mackay</city>
        <state>Queensland</state>
        <zip>4740</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roy Cherian, Dr</last_name>
      <email>roy.cherian@health.qld.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Logan Hospital</name>
      <address>
        <city>Meadowbrook</city>
        <state>Queensland</state>
        <zip>4131</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ken-Soon Tan, Dr</last_name>
      <email>ken-soon.tan@health.qld.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gold Coast University Hospital</name>
      <address>
        <city>Southport</city>
        <state>Queensland</state>
        <zip>4215</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Siddarth Sharma, Dr</last_name>
      <email>Siddharth.Sharma@health.qld.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Central and Northern Adelaide Renal and Transplant Service</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <zip>5000</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Phillip Clayton, Dr</last_name>
      <email>Phil@anzdata.org.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Flinders Medical Centre</name>
      <address>
        <city>Bedford Park</city>
        <state>South Australia</state>
        <zip>5042</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline Milton, Dr</last_name>
      <email>caroline.milton@sa.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Austin Health</name>
      <address>
        <city>Heidelberg</city>
        <state>Victoria</state>
        <zip>3084</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Mount, Dr</last_name>
      <email>Peter.MOUNT@austin.org.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Melbourne Hospital</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3050</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irina Ruderman, Dr</last_name>
      <email>Irene.ruderman@mh.org.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St Vincent's Hospital Melbourne</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3065</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sharon Ford, Dr</last_name>
      <email>sharon.ford@svha.org.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Latrobe Regional Hospital</name>
      <address>
        <city>Traralgon</city>
        <state>Victoria</state>
        <zip>3844</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Solomon Menahem, Dr</last_name>
      <email>solomon.menahem@monash.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Armadale Hospital</name>
      <address>
        <city>Armadale</city>
        <state>Western Australia</state>
        <zip>6112</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hemant Kulkarni, Dr</last_name>
      <email>hemant.kulkarni@health.wa.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Perth Hospital</name>
      <address>
        <city>Perth</city>
        <state>Western Australia</state>
        <zip>6000</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hemant Kulkarni, Dr</last_name>
      <email>hemant.kulkarni@health.wa.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Foothills Hospital/ U of Calgary</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 4Z6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louis Girard</last_name>
      <email>Louis.girard@albertahealthservices.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Paul's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>Bristish Columbia</state>
        <zip>V6Z 1Y6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mercedech Kiaii</last_name>
      <email>mkiaii@providencehealth.bc.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dalhousie University</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H 4R2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karthik Tennankore</last_name>
      <email>KarthikK.tennankore@nshealth.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Queen's University</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <zip>K7L 3N6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Samuel Silver</last_name>
      <email>Samuel.silver@queensu.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>London Health Sciences Centre</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5W9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Matthew Weir</last_name>
      <email>Matthew.weir@lhsc.on.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oakville Trafalgar Memorial Hospital</name>
      <address>
        <city>Oakville</city>
        <state>Ontario</state>
        <zip>L6M 0L8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Danny Sapir</last_name>
      <email>dsapir@haltonhealthcare.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lakeridge Health</name>
      <address>
        <city>Oshawa</city>
        <state>Ontario</state>
        <zip>L1G 2B9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Steele</last_name>
      <email>asteele@lh.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Ottawa Hospital</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1H 8L6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Swapnil Hiremath</last_name>
      <email>shiremath@toh.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Scarborough Hospital Network</name>
      <address>
        <city>Scarborough</city>
        <state>Ontario</state>
        <zip>M1P 2V5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paul Tam</last_name>
      <email>pywtam@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St Michael's Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5B 1W8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ron Wald, Dr</last_name>
      <phone>416-867-3703</phone>
      <email>Ron Wald &lt;Ron.Wald@unityhealth.to&gt;</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Health Network - University of Toronto</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1L7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Charmaine Lok</last_name>
      <email>charmaine.lok@uhn.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Healthcare Toronto</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M6R 1B5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joanna Sasal</last_name>
      <email>Joanna.sasal@unityhealth.to</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Healthcare</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M6R 1B5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Walsh, Dr</last_name>
      <phone>905-522-1155</phone>
      <phone_ext>34055</phone_ext>
      <email>lastwalsh1975@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>McGill University Health Centre</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>4A 3J1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rita Suri</last_name>
      <email>Rsuri.kidney@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Maisonneuve Rosemont</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H1T 2M4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Annie-Claire Nadeau-Fredette</last_name>
      <email>acnadeau-fredette.hmr@ssss.gouv.qc.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jewish General Hospital</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H3T 1E2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Blum</last_name>
      <email>Daniel.blum@mail.mcgill.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sacre Coeur Hospital</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H4J 1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Remi Goupil</last_name>
      <email>remi.goupil@umontreal.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Quebec Universite Laval</name>
      <address>
        <city>Quebec City</city>
        <state>Quebec</state>
        <zip>G1V 4G2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fabrice Mac-Way</last_name>
      <email>Fabrice.mac-way@chudequebec.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Auckland City Hospital</name>
      <address>
        <city>Auckland</city>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Collins, Dr</last_name>
      <email>michael.collins@adhb.govt.nz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Christchurch Hospital</name>
      <address>
        <city>Christchurch</city>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David McGregor, Dr</last_name>
      <email>david.mcgregor@cdhb.health.nz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dunedin Hospital</name>
      <address>
        <city>Dunedin</city>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rob Walker, Prof</last_name>
      <email>rob.walker@otago.ac.nz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Waikato DHB</name>
      <address>
        <city>Hamilton</city>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kannaiyan Rabindranath, Dr</last_name>
      <email>K.Rabindranath@waikatodhb.health.nz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hawkes Bay Hospital</name>
      <address>
        <city>Hastings</city>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annie Reynolds, Dr</last_name>
      <email>annie.reynolds@hawkesbaydhb.govt.nz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Middlemore Hospital</name>
      <address>
        <city>Otahuhu</city>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hari Talreja, Dr</last_name>
      <email>hari.talreja@middlemore.co.nz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Waitematā Hospital</name>
      <address>
        <city>Takapuna</city>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sajed Valappil, Dr</last_name>
      <email>Sajed.Valappil@waitematadhb.govt.nz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northland DHB</name>
      <address>
        <city>Whangarei</city>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adam Mullan, Dr</last_name>
      <email>adam.mullan@northlanddhb.org.nz</email>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Canada</country>
    <country>New Zealand</country>
  </location_countries>
  <link>
    <url>http://aktn.org.au/</url>
    <description>Australasian Kidney Trials Network Website</description>
  </link>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>May 20, 2018</study_first_submitted>
  <study_first_submitted_qc>June 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 29, 2018</study_first_posted>
  <last_update_submitted>September 16, 2021</last_update_submitted>
  <last_update_submitted_qc>September 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Renal dialysis</keyword>
  <keyword>Randomised controlled trial</keyword>
  <keyword>Bone markers</keyword>
  <keyword>Cardiovascular risk factors</keyword>
  <keyword>Phosphate lowering agent</keyword>
  <keyword>End stage kidney disease</keyword>
  <keyword>Hyperphosphatemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
    <mesh_term>Hyperphosphatemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data that underlie the results reported in the primary publication, after deidentification (text, tables, figures and appendices) will be available for individual participant data meta-analysis.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>Beginning 2 years and ending 5 years following main publication. Proposals may be submitted up to 5 years following article publication. After 5 years, the data will be available in our University's data warehouse but without investigator support other than deposited metadata.</ipd_time_frame>
    <ipd_access_criteria>An independent review board will assess proposals based on the following criteria: sound science, benefit-risk balancing and research team expertise.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

